These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 8619542)
1. Obesity and endocrine disorders in women taking valproate for epilepsy. Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542 [TBL] [Abstract][Full Text] [Related]
2. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. El-Khayat HA; Abd El-Basset FZ; Tomoum HY; Tohamy SM; Zaky AA; Mohamed MS; Hakky SM; El Barbary NS; Nassef NM Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076 [TBL] [Abstract][Full Text] [Related]
3. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434 [TBL] [Abstract][Full Text] [Related]
4. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study. Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994 [TBL] [Abstract][Full Text] [Related]
5. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324 [TBL] [Abstract][Full Text] [Related]
6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666 [TBL] [Abstract][Full Text] [Related]
7. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease. Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134 [TBL] [Abstract][Full Text] [Related]
8. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication. Löfgren E; Mikkonen K; Tolonen U; Pakarinen A; Koivunen R; Myllyla VV; Tapanainen JS; Isojärvi JI Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479 [TBL] [Abstract][Full Text] [Related]
9. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome. Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962 [TBL] [Abstract][Full Text] [Related]
10. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Pylvänen V; Pakarinen A; Knip M; Isojärvi J Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693 [TBL] [Abstract][Full Text] [Related]
11. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study. Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558 [TBL] [Abstract][Full Text] [Related]
12. [Hyperinsulinemia, insulin-like growth factor-I, insulin-like growth factor-binding protein-1, and sex-hormone binding-globulin in prepubertal and pubertal girls with premature adrenarche]. Ságodi L; Barkai L; Tombácz A; Vámosi I Orv Hetil; 2003 Jan; 144(2):67-72. PubMed ID: 12632745 [TBL] [Abstract][Full Text] [Related]
13. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases. Isojarvi JI; Tapanainen JS Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991 [TBL] [Abstract][Full Text] [Related]
14. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476 [TBL] [Abstract][Full Text] [Related]
15. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460 [TBL] [Abstract][Full Text] [Related]
16. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Vainionpää LK; Rättyä J; Knip M; Tapanainen JS; Pakarinen AJ; Lanning P; Tekay A; Myllylä VV; Isojärvi JI Ann Neurol; 1999 Apr; 45(4):444-50. PubMed ID: 10211468 [TBL] [Abstract][Full Text] [Related]
17. The role of ghrelin in weight gain and growth in epileptic children using valproate. Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556 [TBL] [Abstract][Full Text] [Related]
18. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1. Pakarinen P; Lähteenmäki P; Rutanen EM Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889 [TBL] [Abstract][Full Text] [Related]